This website is intended for Singapore Healthcare Professionals only
Lagevrio (Molnupiravir) Capsule 200mg
Each capsule contains 200 mg molnupiravir
Each bottle contains 40 capsules
Have a question about an MSD product or want to report an Adverse Event or Quality Issue?
Adverse Events and Product Quality Complaints should be reported.
IF YOU ARE A HEALTHCARE PROVIDER:
Report to MSD at Fax – +65-63966883 or Email – firstname.lastname@example.org;
and report to local health authority at Adverse Event Online Form (hsa.gov.sg) or email email@example.com.
For medical inquiries, contact MSD at firstname.lastname@example.org.
Interim authorization for molnupiravir is provided by Health Sciences Authority, Singapore under pandemic special approval route (PSAR).
Copyright © 2022 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. All rights reserved.